V001-5684 Screening compound: 4-{3-[({4-[4-(4-methoxyphenyl)piperazin-1-yl]-5,6-dimethylpyrimidin-2-yl}sulfanyl)methyl]benzoyl}morpholine

V001-5684 Screening compound: 4-{3-[({4-[4-(4-methoxyphenyl)piperazin-1-yl]-5,6-dimethylpyrimidin-2-yl}sulfanyl)methyl]benzoyl}morpholine
V001-5684 Screening compound: 4-{3-[({4-[4-(4-methoxyphenyl)piperazin-1-yl]-5,6-dimethylpyrimidin-2-yl}sulfanyl)methyl]benzoyl}morpholine alternative view

Chemical Structure Depiction of ChemDiv screening compound V001-5684
4-{3-[({4-[4-(4-methoxyphenyl)piperazin-1-yl]-5,6-dimethylpyrimidin-2-yl}sulfanyl)methyl]benzoyl}morpholine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V001-5684

Molecular Formula

C29H35N5O3S (C29 H35 N5 O3 S)

Compound Name

4-{3-[({4-[4-(4-methoxyphenyl)piperazin-1-yl]-5,6-dimethylpyrimidin-2-yl}sulfanyl)methyl]benzoyl}morpholine

IUPAC name

4-{3-[({4-[4-(4-methoxyphenyl)piperazin-1-yl]-56-dimethylpyrimidin-2-yl}sulfanyl)methyl]benzoyl}morpholine

SMILES

Cc(c(C)n1)c(N(CC2)CCN2c(cc2)ccc2OC)nc1SCc1cc(C(N2CCOCC2)=O)ccc1

InChI

InChI=1S/C29H35N5O3S/c1-21-22(2)30-29(38-20-23-5-4-6-24(19-23)28(35)34-15-17-37-18-16-34)31-27(21)33-13-11-32(12-14-33)25-7-9-26(36-3)10-8-25/h4-10,19H,11-18,20H2,1-3H3

InChI Key

SCGYPYMZKJTCGM-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19825862

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

533.69

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.485

Distribution Coefficient, logD

4.484

Water Solubility, LogSw

-4.43

Polar Surface Area

56.583

Acid Dissociation Constant (pKa)

22.01

Base Dissociation Constant (pKb)

4.99

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

41.40

V001-5684 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

GPCR Targeted Library (31838 compounds)

MCL1 Targeted Library (12200 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V001-5684 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V001-5684?
Check Price and Availability of V001-5684, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V001-5684 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V001-5684
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V001-5684
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V001-5684 available by request